Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹26 Cr.
Stock P/E
11.8
P/B
1
Current Price
₹13
Book Value
₹ 13.5
Face Value
5
52W High
₹18.9
52W Low
₹ 10.7
Dividend Yield
0%

Tejnaksh Healthcare Overview

Business

Tejnaksh Healthcare Ltd. is an India-based company operating in the Hospital & Healthcare Services sector. Its core business model involves providing a range of medical and healthcare services through its healthcare facilities. The company primarily generates revenue by offering inpatient and outpatient care, diagnostic services, surgical procedures, and other specialized medical treatments to patients. This includes revenue from consultation fees, treatment packages, facility charges, and potentially pharmacy sales within its premises.

Revenue Mix

Specific breakdown of revenue by key segments (e.g., inpatient vs. outpatient, diagnostics, specific specialties) is not publicly available in the provided information. However, typical revenue streams for a hospital and healthcare service provider like Tejnaksh would primarily stem from patient services, including general medical consultations, specialized treatments, surgical interventions, intensive care, laboratory tests, imaging services, and pharmacy sales.

Industry

The Indian Hospital & Healthcare Services industry is large, diverse, and experiencing significant growth, driven by increasing healthcare awareness, rising disposable incomes, and a growing incidence of chronic and lifestyle diseases. The industry is characterized by a mix of large corporate hospital chains, regional multi-specialty hospitals, and smaller single-specialty clinics. Tejnaksh Healthcare operates within this competitive landscape. Without specific market share data or details of its operational scale, its positioning is likely as a regional or mid-sized player, potentially focusing on specific geographies or niche services, competing with both larger established chains and other independent hospitals.

MOAT

For a company of this nature, a strong competitive advantage (moat) can be challenging to establish without significant scale, unique specialization, or deep local entrenchment. Tejnaksh Healthcare may possess localized advantages such as strong brand recognition within its operational footprint, established relationships with local medical practitioners, patient loyalty built on trust and quality of service, or strategic geographical placement. However, it is unlikely to have a wide, durable moat based purely on scale or network effects typical of larger players, or high switching costs in a highly competitive market.

Growth Drivers

Key factors that can drive Tejnaksh Healthcare's growth over the next 3-5 years include:

Growing Demand: India's increasing population, rising middle class, and higher health expenditure per capita will continue to fuel demand for healthcare services.

Lifestyle Diseases: The rising prevalence of chronic and lifestyle-related diseases creates a sustained demand for specialized medical care.

Government Initiatives: Schemes like Ayushman Bharat (Pradhan Mantri Jan Arogya Yojana) can increase access to healthcare and patient volumes for empanelled hospitals.

Service Expansion: Introducing new specialties, advanced medical procedures, or diagnostic capabilities to attract a wider patient base.

Geographic Expansion: Opening new facilities or expanding capacity in underserved or high-growth regions.

Risks

Intense Competition: The Indian healthcare market is highly competitive, potentially leading to pricing pressures and challenges in attracting and retaining patients and medical talent.

Regulatory Changes: Changes in healthcare policies, pricing regulations (e.g., caps on medical device costs or procedure charges), and quality standards can impact profitability and operational costs.

Talent Retention: Shortage of skilled doctors, nurses, and paramedical staff, coupled with high attrition rates, can lead to increased wage costs and impact service quality.

Capital Intensive Nature: Operating hospitals requires significant capital expenditure for infrastructure, medical equipment, and technology upgrades, potentially leading to debt accumulation.

Medical Malpractice & Reputation Risk: Incidents of medical errors or service quality issues can severely damage reputation and lead to legal liabilities.

Economic Downturns: Reduced discretionary spending by patients or delays in elective procedures during economic slowdowns can affect patient volumes and revenue.

Management & Ownership

In many Indian companies, promoters (founding families or individuals) typically hold significant ownership stakes and play a crucial role in management and strategic direction. Without specific details on Tejnaksh Healthcare Ltd.'s management team's background, experience, or corporate governance practices, a definitive assessment of management quality is not possible. However, promoter-led management often brings long-term vision but can also concentrate decision-making power. The ownership structure likely involves a substantial promoter holding, common among Indian listed entities.

Outlook

Tejnaksh Healthcare operates in a fundamentally strong growth industry driven by long-term demographic and economic tailwinds in India. The increasing demand for quality healthcare services presents significant opportunities for expansion and revenue growth. However, the company faces considerable challenges from intense competition, the capital-intensive nature of the business, and evolving regulatory frameworks. Its ability to carve out a distinct competitive position, maintain high standards of patient care, effectively manage operational costs, and strategically expand its services and footprint will be crucial for sustained success. The outlook is cautiously optimistic, balancing the sector's robust growth potential against significant operational and competitive hurdles.

Tejnaksh Healthcare Share Price

Live · BSE · Inception: 2008
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Tejnaksh Healthcare Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 3 3 3 3 3 3 3 3 3 3
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 3 3 3 3 3 3 3 3 3 3
Total Expenditure 2 2 2 2 3 2 2 2 2 2
Operating Profit 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 -0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 1 1 1 0 0 0 1 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 1 1 1 0 0 0 0 0 0
Adjustments 0 -0 -0 0 0 0 -0 0 0 0
Profit After Adjustments 0 1 1 1 1 0 0 0 0 0
Adjusted Earnings Per Share 0.2 0.3 0.3 0.3 0.3 0.1 0.2 0.2 0.2 0.1

Tejnaksh Healthcare Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 5 7 14 20 17 12 13 12 12 13 12
Other Income 0 0 0 2 0 0 0 0 0 0 0
Total Income 5 7 15 21 17 12 13 12 12 13 12
Total Expenditure 2 4 9 16 13 8 8 8 9 9 8
Operating Profit 2 3 6 6 4 4 5 4 4 5 4
Interest 0 0 1 1 1 1 0 1 1 0 0
Depreciation 0 0 0 1 1 1 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 3 4 4 3 3 4 3 2 3 1
Provision for Tax 1 1 1 1 1 1 1 1 1 1 0
Profit After Tax 1 2 3 3 2 2 3 2 2 2 0
Adjustments 0 -0 -0 -0 -0 -0 -0 -0 0 0 0
Profit After Adjustments 1 2 3 3 2 2 3 2 2 2 0
Adjusted Earnings Per Share 0.7 0.9 1.4 1.5 1 1 1.3 0.8 0.9 1.1 0.7

Tejnaksh Healthcare Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 6 8 10 13 15 17 20 22 24 26
Minority's Interest 0 0 0 0 0 0 1 1 1 1
Borrowings 0 6 6 6 7 4 6 6 4 1
Other Non-Current Liabilities 0 0 0 1 1 1 1 1 2 2
Total Current Liabilities 0 1 3 2 2 2 2 2 2 1
Total Liabilities 7 16 20 22 25 25 30 31 31 30
Fixed Assets 3 14 15 17 17 15 15 23 23 21
Other Non-Current Assets 3 0 1 1 1 6 9 2 2 3
Total Current Assets 1 2 3 5 7 3 5 6 6 6
Total Assets 7 16 20 22 25 25 30 31 31 30

Tejnaksh Healthcare Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 1 2 1 1 1 1 1 2
Cash Flow from Operating Activities 4 2 4 3 1 1 9 2 4 0
Cash Flow from Investing Activities -3 -8 -3 -2 -1 2 -11 -1 -1 4
Cash Flow from Financing Activities -0 6 -1 -2 0 -3 2 -1 -2 -4
Net Cash Inflow / Outflow 0 1 1 -0 0 -0 0 -0 1 0
Closing Cash & Cash Equivalent 0 1 2 1 1 1 1 1 2 2

Tejnaksh Healthcare Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.65 0.9 1.41 1.49 1.03 1.01 1.34 0.83 0.87 1.15
CEPS(Rs) 0.75 1.11 1.8 1.83 1.38 1.35 1.71 1.31 1.31 1.55
DPS(Rs) 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 3.07 3.97 4.99 6.48 7.51 8.52 9.87 10.72 11.6 12.76
Core EBITDA Margin(%) 48.26 43.84 37.75 21.16 23.6 31.04 37.56 31.57 29.89 31.8
EBIT Margin(%) 44.71 41.7 37.22 26.02 21.77 26.51 33.46 26.74 24.97 27.88
Pre Tax Margin(%) 44.66 39.02 30.28 22.09 17.33 22.31 29.67 21.43 19.51 24.75
PAT Margin (%) 27.84 26.2 22.51 15.88 12.54 17.3 22.18 15.28 14.49 17.29
Cash Profit Margin (%) 32.18 30.98 25.81 18.85 16.36 22.99 27.43 22.73 21.93 24.35
ROA(%) 19.32 16.96 17.97 14.93 9.1 8.36 10.38 5.89 5.64 7.23
ROE(%) 21.17 26.68 34.98 26.93 15.1 12.71 15.05 8.57 7.78 9.02
ROCE(%) 34 29.35 32.66 27.59 17.78 14.2 17.22 11.36 10.76 13
Receivable days 0 0 -0.79 1.48 7.64 15.14 14.86 33.36 31.48 33.57
Inventory Days 13.63 11.91 13.12 14.35 15.67 20.33 20.42 21.59 22.11 22.63
Payable days 115.23 158.84 192.56 204.37 160.23 205.86 110.16 120.22 110 73.7
PER(x) 6.85 44.1 32.72 18.67 17.49 36.02 62.83 41.59 26.49 18.31
Price/Book(x) 1.45 9.97 9.26 4.29 2.4 4.27 8.53 3.22 2 1.64
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 1.8 11.76 7.06 3.12 2.48 6.49 13.82 6.25 3.91 3.25
EV/Core EBITDA(x) 3.68 25.3 17.41 10.74 9.69 20.15 35.69 18.27 12.06 9.3
Net Sales Growth(%) 0 53.42 94.16 39.76 -13.37 -30.13 5.99 -7.49 3.82 5.93
EBIT Growth(%) 0 43.09 73.32 -2.3 -27.52 -14.93 33.79 -26.07 -3.06 18.29
PAT Growth(%) 0 44.39 66.82 -1.45 -31.59 -3.56 35.87 -36.28 -1.54 26.45
EPS Growth(%) 0 37.93 57.36 5.49 -30.92 -1.77 32.68 -38.22 5.54 31.06
Debt/Equity(x) 0 0.79 0.75 0.48 0.47 0.28 0.35 0.29 0.2 0.04
Current Ratio(x) 2.07 2.54 1.03 1.99 3.77 1.89 2.94 3.82 3.86 5.29
Quick Ratio(x) 1.66 2.17 0.79 1.63 3.41 1.48 2.51 3.41 3.33 4.56
Interest Cover(x) 874.41 15.56 5.36 6.61 4.9 6.31 8.84 5.03 4.57 8.9
Total Debt/Mcap(x) 0 0.08 0.08 0.11 0.2 0.07 0.04 0.09 0.1 0.02

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +8% 0% -5% —
Operating Profit CAGR +25% 0% +5% —
PAT CAGR 0% -13% 0% —
Share Price CAGR -27% -26% -22% +2%
ROE Average +9% +8% +11% +18%
ROCE Average +13% +12% +13% +21%

Tejnaksh Healthcare Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 73.83 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 26.17 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 73.8373.8373.8373.8373.8373.8373.8373.8373.8373.83
FII 0.28000000000
DII 0000000000
Public 25.8926.1726.1726.1726.1726.1726.1726.1726.1726.17
Others 0000000000
Total 100100100100100100100100100100

Tejnaksh Healthcare Peer Comparison

Hospital & Healthcare Services Edit Columns

Tejnaksh Healthcare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Tejnaksh Healthcare Pros & Cons

Pros

  • Debtor days have improved from 110 to 73.7days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 8% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp